ArticleThe Science of the total environment2022
Impacts of COVID-19 pandemic on the aquatic environment associated with disinfection byproducts and pharmaceuticals.
Article in The Science of the total environment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 57 citations in OpenAlex.
- Advanced integrated Eco-strategies for effective antibiotic waste management.Biodegradation · 2025Review
- The Effects of Disinfection Byproduct 2,6-Dichloro-1,4-benzoquinone on the CyanobacteriumToxics · 2025Article
- Occurrence, Source Apportionment, and Ecological Risk of Typical Pharmaceuticals in Surface Waters of Beijing, China.Toxics · 2024Article
- Machine learning coupled with causal inference to identify COVID-19 related chemicals that pose a high concern to drinking water.iScience · 2024Article
- Environmental Issues Caused by High-Dose Disinfection Need Urgent Attention.Environment & health (Washington, D.C.) · 2023Article
- Degradation of natural organic matter and disinfection byproducts formation by solar photolysis of free available chlorine.Water research · 2023Article
- Efficient Removal of Analgesic and Anti-Inflammatory Drugs from Sewage Treatment Plant Effluents Using Magnetite Nanoparticles Synthesized Red Mud.Water, air, and soil pollution · 2023Article
- Pilot Study of Pollution Characteristics and Ecological Risk of Disinfection Byproducts in Natural Waters in Hong Kong.Environmental toxicology and chemistry · 2022Article
- Chlorination in the pandemic times: The current state of the art for monitoring chlorine residual in water and chlorine exposure in air.The Science of the total environment · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, concentrations of disinfection byproducts (DBPs) and COVID-19 related pharmaceuticals in wastewater effluents and surface water were measured two weeks, three months and eight months after the lockdown in Wuhan. Little temporal variation in DBP concentrations suggested intensified disinfection during the COVID-19 pandemic had limited impacts on the occurrence of DBPs in the aquatic environment. In contrast, the pandemic led to a significant increase in concentrations of lopinavir and ritonavir in wastewater effluents and surface water. The high detection frequency of these pharmaceuticals in surface water after the lockdown highlighted their mobility and persistence in the aquatic environment. The initial ecological risk assessment indicated moderate risks associated with these pharmaceuticals in surface water. As the global situation is still rapidly evolving with a continuous surge in the number of confirmed COVID-19 cases, our results suggest a pressing need for monitoring COVID-19 related pharmaceuticals as well as a systematic evaluation of their ecotoxicities in the aquatic environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.